Literature DB >> 27067780

Localization of specialized intestinal metaplasia and the molecular alterations in Barrett esophagus in a Japanese population: an analysis of biopsy samples based on the "Seattle" biopsy protocol.

Shota Fukui1, Jiro Watari2, Toshihiko Tomita1, Takahisa Yamasaki1, Takuya Okugawa1, Takashi Kondo1, Tomoaki Kono1, Katsuyuki Tozawa1, Hisatomo Ikehara1, Yoshio Ohda1, Tadayuki Oshima1, Hirokazu Fukui1, Kiron M Das3, Hiroto Miwa1.   

Abstract

It remains unclear why Barrett esophagus (BE)-associated adenocarcinoma (EAC) frequently occurs in the 0 to 3 o'clock area of the BE. The aims of this study were to clarify the localization of specialized intestinal metaplasia (SIM) as a precancerous lesion and of molecular alterations among different locations using 4-quadrant biopsies based on the "Seattle" protocol. We prospectively evaluated microsatellite instability; methylation status at the APC, CDKN2A, hMLH1, RUNX3, and MGMT genes; the immunoreactivity of the monoclonal antibody Das-1 for the colonic phenotype; and Ki-67 staining in 10 early EACs and 128 biopsy samples from 32 BE patients. Among the molecular changes, only APC gene hypermethylation was an independent predictive marker of EAC (odds ratio, 24.4; P = .01). SIM was more frequently identified in the 0 to 3 o'clock quadrant than in the 6 to 9 o'clock quadrant (P = .08). The Ki-67 index was higher in SIM than in the columnar-lined epithelium (CLE) without goblet cells (P < .0001) and in both SIM and CLE with Das-1 reactivity than in those without (P = .04 and P = .06, respectively). Furthermore, the index was relatively higher in the 0 to 3 o'clock quadrant than in the 6 to 9 o'clock quadrant in cases with Das-1 reactivity. RUNX3 methylation was more frequently found in SIM than in CLE (P = .04), whereas the incidence of the other biomarkers did not show a significant difference between the 0 to 3 o'clock and 6 to 9 o'clock areas, nor between SIM and CLE. SIM with Das-1 reactivity, but not molecular alterations, in the 0 to 3 o'clock quadrant may have higher proliferative activity compared to the other areas of the BE.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrett's esophagus; Columnar-lined epithelium; Das-1; Methylation; Microsatellite instability; Specialized intestinal metaplasia

Mesh:

Year:  2016        PMID: 27067780      PMCID: PMC4830918          DOI: 10.1016/j.humpath.2015.12.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  34 in total

1.  Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.

Authors:  Margriet R Timmer; Pierre Martinez; Chiu T Lau; Wytske M Westra; Silvia Calpe; Agnieszka M Rygiel; Wilda D Rosmolen; Sybren L Meijer; Fiebo J W Ten Kate; Marcel G W Dijkgraaf; Rosalie C Mallant-Hent; Anton H J Naber; Arnoud H A M van Oijen; Lubbertus C Baak; Pieter Scholten; Clarisse J M Böhmer; Paul Fockens; Carlo C Maley; Trevor A Graham; Jacques J G H M Bergman; Kausilia K Krishnadath
Journal:  Gut       Date:  2015-06-23       Impact factor: 23.059

2.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

3.  Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus.

Authors:  L H Griffel; P S Amenta; K M Das
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

4.  Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment.

Authors:  Kazuma Fujimoto; Mitsuhiro Fujishiro; Mototsugu Kato; Kazuhide Higuchi; Ryuichi Iwakiri; Choitsu Sakamoto; Shinichiro Uchiyama; Atsunori Kashiwagi; Hisao Ogawa; Kazunari Murakami; Tetsuya Mine; Junji Yoshino; Yoshikazu Kinoshita; Masao Ichinose; Toshiyuki Matsui
Journal:  Dig Endosc       Date:  2013-11-12       Impact factor: 7.559

5.  Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett's esophagus in a Japanese population.

Authors:  Kentaro Moriichi; Jiro Watari; Kiron M Das; Hiroki Tanabe; Mikihiro Fujiya; Toshifumi Ashida; Yutaka Kohgo
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

6.  Gastrointestinal epithelial neoplasia: Vienna revisited.

Authors:  M F Dixon
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

7.  Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions.

Authors:  O Pech; L Gossner; H Manner; A May; T Rabenstein; A Behrens; M Berres; J Huijsmans; M Vieth; M Stolte; C Ell
Journal:  Endoscopy       Date:  2007-07       Impact factor: 10.093

8.  Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus.

Authors:  Doerthe Kuester; Wa'el El-Rifai; DunFa Peng; Petra Ruemmele; Ivonne Kroeckel; Brigitte Peters; Christopher A Moskaluk; Manfred Stolte; Klaus Mönkemüller; Frank Meyer; Hans-Ulrich Schulz; Arndt Hartmann; Albert Roessner; Regine Schneider-Stock
Journal:  Cancer Lett       Date:  2008-11-21       Impact factor: 8.679

9.  Association of promoter methylation of RUNX3 gene with the development of esophageal cancer: a meta analysis.

Authors:  Yi Wang; Xiuguang Qin; Jieqing Wu; Bo Qi; Yipeng Tao; Wenju Wang; Fulei Liu; Hanchen Li; Baosheng Zhao
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

10.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

View more
  3 in total

1.  Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance.

Authors:  Jinyun Li; Dong Ye; Lei Wang; Yingying Peng; Qun Li; Hongxia Deng; Chongchang Zhou
Journal:  Onco Targets Ther       Date:  2018-02-01       Impact factor: 4.147

Review 2.  Barrett's Esophagus and Intestinal Metaplasia.

Authors:  Lu Zhang; Binyu Sun; Xi Zhou; QiongQiong Wei; Sicheng Liang; Gang Luo; Tao Li; Muhan Lü
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

3.  Early diagnostic potential of APC hypermethylation in esophageal cancer.

Authors:  Bujiang Wang; Haojun Song; Haizhong Jiang; Yangbo Fu; Xiaoyun Ding; Chongchang Zhou
Journal:  Cancer Manag Res       Date:  2018-02-01       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.